News > With Master Seed from Astra Zeneca, Serum Institute Manufactures 40 mn Doses of Covishield Vaccine
With Master Seed from Astra Zeneca, Serum Institute Manufactures 40 mn Doses of Covishield Vaccine
E-News | 12/11/2020 04:27 PM | Click to read full article
SII has already manufactured 40 million doses of the vaccine, under the at-risk manufacturing and stockpiling licence from Drugs Controller General of India. Covishield has been developed at the SII Pune laboratory with a master seed from Oxford University/Astra Zeneca.
The promising results of the trials so far give confidence that Covishield could be a realistic solution to the pandemic.